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PCR assays have proved useful for detecting and characterizing Shiga toxin-producing Escherichia coli
(STEC). Recent advances in PCR technology have facilitated the development of real-time fluorescence PCR
assays with greatly reduced amplification times and improved methods for the detection of amplified target
sequences. We developed and evaluated two such assays for the LightCycler instrument: one that simultaneously detects the genes for Shiga toxins 1 and 2 (stx1 and stx2) and another that simultaneously detects the
genes for intimin (eae) and enterohemolysin (E-hly). Amplification and sequence-specific detection of the two
target genes were completed within 60 min. Findings from the testing of 431 STEC isolates of human and
animal origin, 73 isolates of E. coli negative for stx genes, and 118 isolates of other bacterial species with the
LightCycler PCR (LC-PCR) assays were compared with those obtained by conventional block cycler PCR
analysis. The sensitivities and specificities of the LC-PCR assays were each 100% for the stx1, eae, and E-hly
genes and 96 and 100%, respectively, for the stx2 gene. No stx2 genes were detected from 10 stx2f-positive isolates
because of significant nucleotide differences in their primer annealing regions. Melting curve analyses of the
amplified Shiga toxin genes revealed sequence variation within each of the tested genes that correlated with
described and novel gene variants. The performance characteristics of the LC-PCR assays, such as their speed,
detection method, and the potential subtyping information available from melting curve analyses, make them
attractive alternatives to block cycler PCR assays for detecting and characterizing STEC strains.
gene(s) being amplified. The extent of postamplification manipulation of samples generally performed for conventional
PCR assays also carries significant risk of contaminating the
work environment with amplification products. Recent advances in fluorescence-based, real-time PCR techniques have
facilitated the development of assays that offer rapid, simultaneous amplification and sequence-specific detection of two
target genes in a single reaction tube. In the present study, we
developed and evaluated two duplex real-time fluorescence
PCR assays for the LightCycler instrument for the detection
and genotypic characterization of STEC.

Shiga toxin-producing Escherichia coli (STEC) strains, also
referred to as verocytotoxin-producing E. coli strains, are an
important cause of food-borne disease worldwide. STEC
strains produce one or more potent cytotoxins and are capable
of causing watery diarrhea, bloody diarrhea, hemolytic uremic
syndrome (HUS), thrombotic thrombocytopenic purpura, and
death (6, 18, 19, 33, 38, 41). STEC strains constitute a serologically and biochemically heterogeneous group of organisms
and are most reliably detected by methods that target the
toxins they produce or the genes encoding these toxins. Among
the methods that target the toxin genes, PCR assays have been
used widely to detect small numbers of STEC present in stool
specimens, enrichment broths, or primary fecal cultures (2, 10,
12, 16, 25, 27, 28, 31, 36). PCR assays have also been used
extensively to characterize STEC strains with respect to other
virulence and virulence-associated genes (1, 8, 14, 20, 21, 23,
26, 31). While conventional PCR assays are versatile from the
standpoint of being able to detect and identify multiple target
genes in one reaction, most first-generation PCR assays have
cumbersome procedures for detecting the amplification products and many lack sequence-specific identification of the

MATERIALS AND METHODS
Bacterial strains. E. coli strains included in the study were selected from the
culture collections of our institutions and are described in Table 1. We studied
504 E. coli isolates, consisting of 431 STEC and 73 non-STEC, and 118 strains
from the following bacterial genera: Treponema (1), Borrelia (3), Leptospira (1),
Helicobacter (2), Legionella (5), Neisseria (2), Branhamella (1), Xanthomonas (1),
Moraxella (2), Kingella (1), Acinetobacter (1), Sphingomonas (1), Pseudomonas
(4), Brucella (2), Bordetella (4), Shigella (4; including Shigella dysenteriae type 1),
Salmonella (2), Citrobacter (2), Klebsiella (2), Enterobacter (2), Serratia (2), Proteus (2), Morganella (1), Providencia (1), Yersinia (2), Vibrio (1), Aeromonas (1),
Pasteurella (1), Haemophilus (3), Actinobacillus (1), Bacteroides (1), Campylobacter (3), Fusobacterium (1), Eikenella (1), Prevotella (1), Porphyromonas (1),
Rickettsia (1), Ehrlichia (1), Coxiella (1), Bartonella (2), Chlamydia (3), Mycoplasma (2), Ureaplasma (1), Micrococcus (1), Staphylococcus (5), Streptococcus
(5), Leuconostoc (1), Pediococcus (1), Peptostreptococcus (3), Bacillus (2), Clostridium (3), Lactobacillus (2), Listeria (1), Corynebacterium (5), Gardnerella (1),
Propionibacterium (1), Actinomyces (2), Mycobacterium (4), Nocardia (2), Tsukamorella (1), Rhodococcus (1).

* Corresponding author. Mailing address: Institut für Medizinische
Mikrobiologie und Hygiene, Universitätsklinikum Regensburg, FranzJosef-Strau␤-Allee 11, D-93053 Regensburg, Germany. Phone: 49941-944-6450. Fax: 49-941-944-6402. E-mail: Udo.Reischl@klinik.uni
-regensburg.de.
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TABLE 1. Characteristics of E. coli and other bacterial strains tested by conventional and LC-PCR
Genotype
stx1

stx2

eae

E-hly

No. of
strains

⫹

⫺

⫹

⫹

135

⫺

⫹

⫹

⫹

89

⫹

⫹

⫹

⫹

87

⫺

⫹

⫺

⫺

48

⫺

⫺

⫺

⫺

159

⫺

⫺

⫹

⫺

24

⫹

⫹

⫺

⫹

24

⫺

⫹

⫺

⫹

12

⫺

⫹

⫹

⫺

11

⫹

⫺

⫺

⫺

11

⫺
⫹
⫹
⫹
⫹

⫺
⫹
⫺
⫺
⫹

⫹
⫺
⫹
⫺
⫹

⫹
⫺
⫺
⫹
⫺

7
6
6
2
1

Total

Serotypea

O26:H11/NM (70), O45:H2 (10), O46:H2 (1), O63:NM (1), O84:NM (1), O91:NM
(1), O103:H2/H18/H25/NM (21), O111:H2/H8/NM (14), O125:NM (1), O145:NM
(7), O153:H2 (1), O157:H7/NM (2), Orou:H2 (1), Orou:H11 (1), Orou:NM (1),
Ound:NM (2)
O2:NM (1), O14:NM (1), O26:H11/NM (16), O103:H2/NM (5), O121:H19 (5),
O144:NM (3), O145:NM (14), O157:H7/NM (41), O165:H25 (1), Orou:NM (1),
Ound:NM (1)
O4:NM (1), O26:H11/NM (16), O75:NM (1), O111:H2/H8/NM (20), O145:NM (2),
O120:NM (1), O145:NM (2), O157:H7/NM (43), Ound:NM (1)
O2:H5 (1), O8:H14/NM (2), O16:H32/H48 (2) O22:H5 (1), O23:NM (1), O28:H25
(1), O30:NM (1), O40:H6/NM (2), O60:H2/NM (4), O73:H17 (2), O79:H7 (1),
O77:NM (1), O80:H42 (1), O92:NM (1), O101:H9 (1), O103:NM (1), O113:H21
(1), O121:H19 (1), O128:H45 (2), O140:NM (1), O146:NM (1), O162:NM (1),
O171:H2 (1), OX3:H21 (1), Orou:NM (3), Ound:NM (13)
O1:H7 (1), O2:NM (1), O4:H5 (1), O6:H1/H10/H16/H31/NM (5), O8:H42 (1),
O11:H18 (1), O16:H5/H7 (2), O18:H1/H7 (3), O22:NM (1), O25:H4 (1), O34:H10
(1), O49:NM (1), O50:H7 (1), O62:H30 (1), O63:H20 (1), O64:NM (1), O75:NM
(3), O88:H7 (1), O128:H27 (1), O135:H4 (1), O146:H28 (1), O148:H28/NM (4),
O167:H5/NM (2), O169:H41 (1), Orou:H16/NM (4), Ound:H32 (1), bacterial
species other than E. coli (117)
O2ab:H2 (1), O6:H1 (1):O37:NM (1), O53:NM (1), O55:NM (1), O63:NM (2),
O86:H34 (1), O88:H25 (1), O101:NM (1), O111:NM (2), O119:H2/H6: (2),
O128:H2 (1), O130:NM (1), O132:H34 (1), O142:NM (1), O145:H34 (1),
O163:H6 (1), O170:NM (1), Orou:NM (1), Ound:H45/NM (2)
O60:H19 (1), O8:NM (1), O22:H8 (1), O62:NM (1), O70:NM (1), O75:H21 (1),
O88:25 (1), O96:NM (1), O111:NM (1), O113:NM (2), O128:H2/NM (5),
O128:NM (1), O137:H41(1), Ound:H8/NM (2), Orou:H19/NM (2), Ound:NM (2)
O2:H8 (1), O5:H21(1), O6:NM (1), O8:NM (1), O26:H19 (1), O38:H21 (1),
O91:H21 (1), O104:H21 (2), O110:H28 (1), O113:H21 (1), O112:NM (1)
O15:NM (1), O26:NM (1), O55:H7 (1), O63:H6 (1), O66:NM (1), O83:H19 (1),
O128:NM (3), O135:NM (1), Ound:NM (1), Ound:NM (1)
O75:NM (1), O91:H14/NM (2), O112:NM (2), O117:H7 (1), O121:H7 (2), O146:H2
(1), Ound:H52 (1), S. dysenteriae type 1 (1)
O26:H4/H11 (2), O103:NM (1), O143:NM (1), O157:H7/NM (2), Orou:NM (1)
O28:H25 (1), O91:NM (1), O128:NM (1), O162:NM (1), Ound:NM (2)
O5:NM (1), O14:H11 (1), O26:H11 (1), O111:H8/NM (2), O119:H2 (1)
O112:NM (1), Orou:NM (1)
O83:H1 (1)

622

a

Ound and Hund, O and H antigen, respectively, not determined with available typing sera; Orou, O antigen not determined because of incomplete or rough
lipopolysaccharide; NM, nonmotile. Numbers in parentheses indicate number of strains with that serotype.

The serotype and presence of the genes for Shiga toxins 1 and 2 (stx1 and stx2),
enterohemolysin (E-hly), and intimin (eae) for the E. coli isolates are summarized in Table 1. Of the E. coli isolates included, all except 10 were from human
sources; the 10 exceptions were positive for the stx2f genes by PCR (35) and were
isolated from pigeons. E. coli strains used as controls included ATCC 43895,
containing the genes for stx1, stx2, eae, and E-hly; ATCC 43889, containing the
genes for stx2, eae, and E-hly; and ATCC 43890, containing the genes for stx1, eae,
and E-hly. The following stx-negative diarrheagenic strains were used: H10407
(O78:H11), containing the genes for thermostable and thermolabile enterotoxins; TX1 (O78:H12), containing the gene for thermostable enterotoxin; B170
(O111:NM), containing the genes for eae, bfpA, and the EAF plasmid; EDL1284
(O124:NM), containing the genes for ipaH; and 3591-78 (O75:NM), containing
the plasmid involved in mediating the enteroaggregate-type adherence to HEp-2
cells in vitro.
Bacterial isolates were stored frozen at ⫺70°C in tryptic soy broth containing
10% glycerol and were subcultured prior to testing onto either MacConkey agar
(Merck, Darmstadt, Germany) or tryptic soy agar containing 5% sheep blood.
Serologic characterization. Serologic testing for O and H antigens was performed by standard methods using microtitration plates instead of tubes (7).
Preparation of template DNA. To prepare template DNA from pure bacterial
cultures, a 1-cm-long sweep of bacterial growth from the quadrant of the MacConkey or blood agar plate with heaviest growth was suspended in 300 l of lysis
buffer composed of 10 mM Tris-HCl (pH 8.0), 1% Triton X-100, 0.5% Tween 20,

and 1 mM EDTA (37). The bacterial suspension was heated at 99.9°C for 10 min
and then centrifuged at 1,000 ⫻ g for 2 min to sediment the debris. Aliquots (2
to 5 l) of the clear DNA supernatant were then directly transferred to the
PCRs.
Block cycler PCR assays. Genes associated with STEC were detected by PCR
by using previously described methods and the primers listed in Table 2. A 5-l
aliquot of supernatant from the boiled suspension of bacterial cells was used as
the source of template DNA in 50-l reaction mixtures consisting of 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, a 200 M
concentration of each deoxynucleoside triphosphate, a 0.4 M concentration of
each primer, and 2 U of Taq DNA polymerase. Thermocycling conditions for the
individual amplification reactions and the expected size of the amplicons are
listed in Table 2.
In addition to reactions performed with template DNA from known positive
and negative control strains, a reaction mixture containing water instead of
template was included in each experiment to detect possible reagent contamination. Amplified fragments were separated by agarose gel electrophoresis and
visualized after ethidium bromide staining with UV illumination. PCR was also
performed on 5 to 10 individual colonies to isolate STEC from mixed bacterial
cultures that had initially tested positive for stx genes.
Subtyping of the stx2 genes was accomplished by restriction fragment analysis
of amplicons generated by block cycler PCR restriction fragment length polymorphism assays (PCR-RFLP) or by toxin-specific block cycler PCR assays. To
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TABLE 2. Oligonucleotide primers used in the detection and characterization of STEC by conventional PCR
Target
gene

stxB1
stxB2
stxB2/2c
stxB2d
stxB2e
stxA2f
stxA/B2d
stxA/B2e
eae
E-hly
a
b

Primer

Primer sequence (5⬘–3⬘)a

SLTI-1
SLTI-2
SLTII-1
SLTII-3
GK3
GK4
VT2-cm
VT2-f
FK1
FK2
128-1
128-2
SD-a
SD-b
SE-a
SE-b
C1
C2
MFS1F
MFSIR

CAg TTA ATg Tgg Tgg CgA Ag
CAC AgA CTg CgT CAg TgA gg
CTT Cgg TAT CCT ATT CCC gg
CgC TgC AgC TgT ATT ACT TTC
ATg AAg AAg ATg TTT ATg
TCA gTC ATT ATT AAA CTg
AAg AAg ATA TTT gTA gCg g
TAA ACT gCA CTT CAg CAA AT
CC ggA TCC AAg AAg ATg TTT ATA g
CCC gAA TTC TCA gTT AAA CTT CAC C
AgA TTg ggC gTC ATT CAC Tgg TTg
TAC TTT AAT ggC CgC CCT gTC TCC
ATT TAC CAg gCT CgC TTT Tg
ACA TTg CTg CAC ACT ACg
gAg CAg ACg ACA CgA TAA CA
AAT CAg CAT CCA CAA CAC TA
TCg TCA CAg TTg CAg gCC Tgg T
CgA AgT CTT ATC CgC CgT AAA gT
ACg ATg Tgg TTT ATT CTg gA
CTT CAC gTC ACC ATA CAT AT

Amplification conditionsb

Amplicon
size (bp)

35 ⫻ (95°C, 15 s; 60°C, 45 s; 72°C, 1.5 min)

475

35 ⫻ (95°C, 15 s; 60°C, 45 s; 72°C, 1.5 min)

863

35 ⫻ (94°C, 30 s; 52°C, 1 min; 72°C, 40 s)

260

35 ⫻ (94°C, 30 s; 52°C, 1 min; 72°C, 1 min)

256

35 ⫻ (94°C, 30 s; 55°C, 1 min; 72°C, 40 s)

280

35 ⫻ (94°C, 30 s; 57°C, 1 min; 72°C, 1 min)

428

Reference

30 ⫻ (94°C, 30 s; 53°C, 1 min; 72°C, 1.5 min)

1,361

25
25
25
25
17
17
35
35
9
9
40
40
Present study

30 ⫻ (94°C, 30 s; 53°C, 1 min; 72°C, 1.5 min)

1,547

Present study

35 ⫻ (94°C, 20 s; 53°C, 45 s; 72°C, 1.5 min)

1,110

35 ⫻ (94°C, 20 s; 53°C, 45 s; 72°C, 1.5 min)

166

21
21
10
10

g ⫽ guanosine. A lowercase letter is used for this nucleotide to avoid confusion with C (cytosine) in the printed table.
Total cycle numbers, temperatures, and periods of denaturation, annealing, and elongation steps are given.

differentiate stx2 from stx2c, PCR-RFLP was performed with primers GK3 and
GK4 (17) and amplicons were digested with the restriction endonucleases HaeIII
and FokI (Roche Diagnostics, Mannheim, Germany) as described by Rüssmann
et al. (39). Toxin-specific PCR assays were used to characterize stx2d, stx2e, and
stx2f: stx2d was detected by using primers VT2-cm and VT2-f (35), stx2e was
detected by using primers FK1 and FK2 (9), and stx2f was detected by using
primers 128-1 and 128-2 (40). To amplify the complete A- and B-subunit genes
for sequencing, primers SD-a and SD-b were used for stx2d and primers SE-a and
SE-b were used for stx2e.
Oligonucleotide primers and fluorescent-labeled probes for the LightCycler
PCR (LC-PCR) assays. DNA oligonucleotide primers and hybridization probes
were synthesized by TIB Molbiol, Berlin, Germany, and by the Biotechnology
Core Facility, Centers for Disease Control, Atlanta, Ga. Hybridization probes
were labeled with fluorescein, LC Red 640, or LC Red 705. The nucleotide
sequences of primers and hybridization probes and their corresponding locations
within the representative GenBank sequences are shown in Table 3. Oligonucleotide sequences for the hybridization probes were selected using Oligo (version 6.0; Molecular Biology Insights, Inc., Cascade, Colo.) to have comparable
Tm values, moles percent G⫹C content within the range of 35 to 60%, and

minimal secondary structure due to self-complementarity or palindromic sequences.
LC-PCR assay and product detection. All LC-PCR assays were performed
using a fluorescence temperature cycler (LightCycler; Roche Diagnostics). The
amplification mixture consisted of 2 l of 10⫻ reaction mix (LightCycler-FastStart Master Hybridization Probes; Roche Diagnostics), 3 mM MgCl2, 0.5 M
concentrations of each oligonucleotide primer, 0.2 M concentrations of each
oligonucleotide probe, and 2 l of template DNA in a final volume of 20 l.
Samples were amplified with an initial denaturation step at 95°C for 10 min to
activate the FastStart Taq DNA polymerase and 50 cycles of denaturation at
95°C for 10 s, annealing at 50°C for 20 s, and an extension at 72°C for 30 s. The
temperature transition rate was 20°C/s. The generation of target amplicons for
each sample was monitored between the annealing and the elongation steps at
640 and 705 nm. Samples positive for target genes were identified by the instrument at the cycle number where the fluorescence attributable to the target
sequences exceeded that measured for background. Those scored as positive by
the instrument were confirmed by visual inspection of the graphical plot (cycle
number versus fluorescence value) generated by the instrument.
Following the amplification phase, a melting curve analysis (starting at 40°C)

TABLE 3. Oligonucleotide primers and LightCycler hybridization probes used in the PCR assay
Oligonucleotide

Sequencea

Target
gene(s)

Nucleotide
position

GenBank
accession no.

STEC-1
STEC-2
STEC-I HP-1
STEC-I HP-2
STEC-II HP-1
STEC-II HP-2

gA(Ag) C(Ag)A AAT AAT TTA TAT gTg
TgA TgA Tg(Ag) CAA TTC AgT AT
TTT ACg TTT TCg gCA AAT ACA gAg ggg AT-[FL]
[Red 640]-TCg TAC AAC ACT ggA TgA TCT CAg Tgg g-Ph
TCA ggC ACT gTC TgA AAC TgC TCC TgT gTA-[FL]
[Red 705]-ACC ATg ACg CCg ggA gAC gTg gAC CT-Ph

stx1 and stx2
stx1 and stx2
stx1
stx1
stx2
stx2

280–300
800–781
570–598
601–627
778–807
809–834

AB015056
AB015056
AB015056
AB015056
Z37725
Z37725

Present
28
Present
Present
Present
Present

eaeAF
eaeAR
eae-HP-1
eae-HP-2

gAC CCg gCA CAA gCA TAA gC
CCA CCT gCA gCA ACA AgA gg
ACA gTT CTg AAA gCg AAA TgA TgA Agg C-[FL]
[Red 640]-CCT ggT CAg CAg ATC ATT TTg CCA CT-Ph

eae
eae
eae
eae

24875–24894
25258–25239
25132–25159
25164–25189

AF022236
AF022236
AF022236
AF022236

31
31
Present study
Present study

hlyAF
hlyAR
hlyA HP-1
hlyA HP-2

gCA TCA TCA AgC gTA CgT TCC
AAT gAg CCA AgC Tgg TTA AgC T
gCA Tgg CTC TTg ATg AAT TgC TgA gA-[FL]
[Red 705]-CAA Cgg gAA ggA gAg gAT ATA AgT CAg-Ph

E-hly
E-hly
E-hly
E-hly

X94129
X94129
X94129
X94129

31
31
Present study
Present study

70–90
602–581
434–459
464–489

Reference

study
study
study
study
study

a
[FL], fluorescein; [Red 640], LC Red 640–N-hydroxy-succinimide ester; [Red 705], LC Red 705-phosphoramidite; [Ph], 3⬘-phosphate. g ⫽ guanosine. A lowercase
letter is used for this nucleotide to avoid confusion with C (cytosine) in the printed table.
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was performed with a temperature transition rate of 0.2°C/s to determine the Tm
values for the sequences targeted by the hybridization probes. Tm values were
manually assigned from a plot generated by the instrument of the negative
derivative of fluorescence versus temperature (⫺dF/dT) of the melting curve for
amplification products measured at 640 and 705 nm.
Sensitivity of LC-PCR assays and protocol using LC-PCR assays for STEC
detection in stool. To assess the sensitivity of the PCR assays for the four target
genes, E. coli ATCC 43895 was grown at 37°C in brain heart infusion broth to an
optical density at 600 nm of 0.7 to 0.8 and diluted 10-fold in phosphate-buffered
saline to yield 101 to 1010 CFU/ml as estimated by a standard plating procedure.
DNA templates from a 300-l aliquot of each dilution were prepared and 2-l
aliquots were tested in the LC-PCR assays and the block cycler PCR assays as
described above to determine the minimum number of CFU per reaction mixture that could be detected by each method. In addition, 0.5-g portions of stool
from a healthy volunteer were suspended in 0.5-ml aliquots of each bacterial
dilution containing known numbers of CFU/ml to estimate the sensitivity of the
assay for detecting the target genes in clinical specimens. For each spiked stool
suspension (50% [wt/vol] stool suspension), a 5-l aliquot was inoculated onto a
MacConkey agar plate, streaked for isolated colonies, and incubated for 16 to
18 h at 35°C. The bacterial growth from the entire plate was harvested into 1.5
ml of lysis buffer as described above and processed for template DNA. A 2-l
aliquot of each sample was tested for STEC target genes by LC-PCR and block
cycler PCR assays.
Nucleotide sequence analysis of PCR products. Amplification products were
purified using the HighPure PCR Product Purification kit (Roche Diagnostics),
and cycle sequencing reactions of the stx1 and stx2 amplicons were performed as
described in the PRISM Ready Reaction Dye Deoxy Terminator cycle sequencing kit protocol (Applied Biosystems, Weiterstadt, Germany). Both strands of
amplicons originating from different amplification reactions were sequenced in
duplicate to rule out the possibility of Taq DNA polymerase-induced errors.
Optimal results were obtained using STEC-1 as the forward and STEC-2 as the
reverse sequencing primer. The fluorescence-labeled reaction products were
analyzed with an ABI PRISM 310 Genetic Analyzer (Applied Biosystems). To
determine the complete sequence of the stx2d gene, amplification primers SD-a
and SD-b (Table 2), which span subunit genes stxA2d and stxB2d, were used for
cycle sequencing reactions. Likewise, amplification primers SE-a and SE-b (Table 2), which span subunit genes stxA2e and stxB2e, were used to sequence the
complete stx2e gene.
Nucleotide sequence accession numbers. For the sequence of the stx2 amplicon
from strain 3143-97 with the 51°C melting point (described below), the sequence
of a 1,324-bp region of the stx2 gene was determined and deposited in GenBank
under accession no. AJ313015. For the nucleotide sequence of the stx2e gene
from strain 3615-99 with the 63°C melting point (described below), a 1,509-bp
region of its sequence was determined and deposited in GenBank under accession no. AJ313016.

RESULTS
Strategy for duplex LC-PCR assay design. The two duplex
real-time fluorescence PCR assays for the LightCycler simultaneously detect the most common virulence and virulenceassociated genes present in STEC. We designed the assays to
have identical amplification conditions so that both could be
run at the same time on the instrument. By measuring the
fluorescence values at 640 and 705 nm, we were able to detect
stx1 and stx2, respectively, in one reaction capillary and eae and
E-hly, respectively, in another reaction capillary. We used degenerate primer sequences from published primers (28) targeting conserved regions within the A subunit genes of stx1 and
stx2 to give 512-bp and 518-bp amplicons, respectively, and we
designed sets of hybridization probes, consisting of a “sensor”
probe and an “anchor” probe, against sequences internal to the
amplified regions of the target genes. We designed the sensor
hybridization probes STEC-I HP-2 and STEC-II HP-2 to have
a lower theoretical melting temperature than their anchor
counterparts STEC-I HP-1 and STEC-II HP-1. We followed a
similar strategy for comparably sized amplicons for the design
of primers and hybridization probes targeting the genes encod-
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ing intimin (eae) and enterohemolysin (E-hly) (31). Graphs
depicting the accumulation of fluorescence throughout the
PCR for stx1, stx2, eae, and E-hly are shown in Fig. 1 for a panel
of representative strains.
Sensitivity and specificity of duplex LC-PCR assays for detecting target genes in pure bacterial culture. To assess the
ability of the LC-PCR assays to detect the four target genes in
a serologically diverse collection of bacteria, we tested 504
isolates of E. coli and 118 isolates of other bacterial species
with the LC-PCR assays and compared these findings with
those obtained by block cycler PCR assays. The correlation of
duplex LC-PCR and block cycler PCR findings and the sensitivities and specificities of the LC-PCR assays for detecting
stx1, stx2, eae, and E-hly genes in pure bacterial cultures are
summarized in Table 4. With the exception of the 10 stx2fpositive isolates from pigeons, the findings from the duplex
LC-PCR assays and block cycler PCR assays were in complete
agreement for all four target genes. The failure of the LC-PCR
assay to detect stx2f was attributed to substantial nucleotide
sequence differences between the stx primers and the primer
annealing regions of the stx2f gene. Among the strains tested,
the positive predictive values of the LC-PCR assays for stx1,
stx2, eae, and E-hly were each 100%, and the negative predictive values for these genes were 100, 97, 100, and 100%, respectively.
Time requirements for LC-PCR and block cycler PCR assays. We performed 50 amplification cycles for the LC-PCR
assays, which typically took 60 min to accomplish. For most
samples, however, we could discriminate between PCR-positive and -negative samples after only 30 cycles, which took
approximately 30 min to accomplish. Block cycler PCR assays
with agarose gel detection of amplicons typically took 4.5 to 5 h
to complete.
Differentiation of stx variants, eae, and E-hly by melting
curve analysis. Since considerable sequence heterogeneity exists among the described prototype and variant stx genes, we
positioned the stx1- and stx2-specific sets of hybridization
probes over hypervariable regions within the amplicon to distinguish gene variants by subsequent melting curve analyses.
Sharp and clearly interpretable melting curves (plotted as the
negative derivative of fluorescence versus temperature) were
obtained with all tested stx1- and/or stx2-positive STEC isolates.
With the majority of stx1-positive strains, we observed a
melting point of 68°C. This corresponds to a perfect match of
hybridization probes STEC-I HP-1 and STEC-I HP-2 with the
stx1 sequence AB015056 that has been deposited in GenBank
(15). We noted reduced melting points for two stx1-positive E.
coli strains: 62°C for strain 3394-00 (serotype O121:H7) and
65°C for strain 3143-97 (serotype O22:H8) (Fig. 2A). Findings
from comparative nucleotide sequence analyses of the stx1
amplicons from strains 3394-00 and 3143-97 revealed partial
and complete homologies, respectively, between these genes
and the sequence of a variant stx1 gene from a strain described
by Paton et al. (E. coli serotype OX3:H8; GenBank sequence
Z36901) (30). We observed five and two nucleotide mismatches between the sequences of 3394-00 and 3143-97, respectively, and the sequences of the hybridization probes,
which account for the reduced melting points of these isolates
compared with those obtained for strains whose stx1 genes are
completely homologous to the probes. Melting curve analyses
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FIG. 1. Amplification of stx1 and stx2 (A and B) and eae and E-hly (C and D) in duplex LC-PCR assays. Graphs depict fluorescence at 640 and
705 nm versus cycle number for the following E. coli strains with varied combinations of target genes: ■, O157:H7 (stx1 positive; stx2 positive; eae
positive; E-hly positive); F, O45:H2 (stx1 positive; stx2 negative; eae positive; E-hly positive); E, O26:H11 (stx1 positive; stx2 negative; eae positive;
E-hly positive); 䊐, O110:H28 (stx1 negative; stx2 positive; eae negative; E-hly positive); x, O113:H21 (stx1 negative; stx2 positive; eae negative; E-hly
positive); and 哹, negative control.

of stx1 amplification products from representative strains with
the 68, 62, and 65°C melting points and their corresponding
sequence alignments are shown in Fig. 2.
Because several subtypes of stx2 have been described, we
examined the strains in our collection for which toxin subtype
information was available by block cycler PCR or PCR-RFLP
analysis for possible correlations between the melting points of
the stx2 hybridization probes and the type of stx2 gene possessed. Findings from this comparison are summarized in Ta-

TABLE 4. Correlation of conventional PCR and LC-PCR
results for 622 bacterial isolates
Target
gene

stx1
stx2
eae
E-hly
a

Results with
conventional/LC PCR
⫹/⫹

⫺/⫹

⫹/⫺

⫺/⫺

272
268
360
356

0
0
0
0

0
10a
0
0

350
344
262
266

Sensitivity
(%)

Specificity
(%)

100
96
100
100

100
100
100
100

Ten of 10 stx2f isolates were not detected by the LC-PCR assay.

ble 5, and melting curve profiles for representative strains of
the five different melting temperatures observed are shown in
Fig. 3A. Among the 117 strains included in this comparison, we
observed melting points of 71°C for all 51 strains whose stx2
genes were characterized as either the prototype stx2 (n ⫽ 27),
stx2c (n ⫽ 18), or a combination of these genes (n ⫽ 6). This
melting point reflects a perfect match and a 1-nucleotide mismatch between the hybridization probes STEC-II HP-1 and
STEC-II HP-2, respectively, and the prototype stx2 sequence
AE005296 deposited in GenBank (32).
Among the 40 STEC strains that were positive for stx2d, we
observed a melting point of 55°C for 39 strains and a melting
point of 51°C for one strain (3143-97, serotype O22:H8) (Table
5). Findings from the comparative nucleotide sequence analysis of the stx2 amplicon from a representative strain with the
55°C melting point, 811-1 (serotype O128:H2) versus those
stored in GenBank showed complete homology between it and
the sequence of the stx2d gene deposited under GenBank
L11078 (27) (Fig. 3B and C). In contrast, the sequence of the
stx2 amplicon from strain 3143-97 with the 51°C melting point
differed from those in GenBank, which prompted us to deter-
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TABLE 5. Melting peak temperatures of the stx2 LightCycler hybridization probes for 117 STEC strains whose stx2 genes
were previously characterized by block cycler PCR and PCR-RFLP
stx2 gene(s)
present

No. of
strains

Melting
temp. (°C)

stx2

27

71

stx2c

18

71

stx2 and stx2c
stx2d

6
39

71
55

stx2e

1b
15
1c
10

51
66
63
No melting

stx2f
Total

117

Serotype(s)a

O6:NM (1), O26:H11/NM (7), O103:H2 (1), O111:NM (3), O145:NM (1), O157:H7/NM (13),
Ound:NM (1)
O23:NM (1), O30:NM (1), O77:NM (1), O92:NM (1), O120:NM (1), O145:NM (2), O157:H7/NM (10),
Orou:NM (1)
O157:H7 (6)
O8:NM (1), O16:H32/H48 (2), O40:H6/NM (2), O62:NM (1), O70:NM (1), O75:H21 (1), O91:NM (1),
O96:NM (1), O103:NM (1), O113:NM (2), O128:H2/NM (8), O140:NM (1), O146:NM (1), O162:NM
(1), Orou:H19/NM (4), Ound:H8 (4), Ound:NM (7)
O22:H8 (1)
O2:H5 (1), O8:Hund (1), O60:NM (2), O60:H2/NM (4), O101:H9 (1), Ound:NM (6)
Ound:NM (1)
O15:NM (1), O26:NM (1), O66:NM (1), O83:H19 (1), O128:NM (3), O135:NM (1), Ound:NM (1),
Ound:NM (1)

a

Ound and Hund, O and H antigen, respectively, not determined with available typing sera; Orou, O antigen not determined because of incomplete or rough
lipopolysaccharide; NM, nonmotile. Numbers in parentheses indicate number of strains with that serotype.
b
Nucleotide sequence variant of stx2d.
c
Nucleotide sequence variant of stx2e.

mine the sequence of a 1,324-bp region of its stx2 gene and
deposit it in GenBank under accession no. AJ313015. Alignment of the stx2d sequences from strains 811-1 and 3143-97
with those of the hybridization probes revealed four and five
mismatches, respectively, between the target genes and hybridization probe STEC-II-HP-2. Three and four of these mismatches account for the reduced melting points of the stx2d
strains relative to those observed for the prototype stx2 and
stx2c genes.
Among the 16 strains that were positive for stx2e, we detected melting points of 66°C for 15 strains and a melting point
of 63°C for one strain (3615-99, serotype Ound:NM) (Table 5).
Findings from the comparative nucleotide sequence analysis of
the stx2e amplicon from a representative strain with the 66°C
melting point (strain 3357-98, serotype O60:NM) revealed a
perfect match between it and the stx2e GenBank sequence
X81416 (9). Alignment of the sequence from this strain with
the sequences of the hybridization probes revealed two nucleotide mismatches between it and hybridization probe STECII-HP-2, one of which accounts for the reduction in melting
points observed for stx2e-positive strains compared with those
obtained for prototype stx2- and stx2c-positive strains (Fig. 3B
and C). The nucleotide sequence of the stx2e gene from strain
3615-99 with the 63°C melting point differed from other stx2
sequences deposited to date in GenBank, and a 1,509-bp region of its sequence was determined and deposited in GenBank under accession no. AJ313016. A similar alignment of its
sequence with those of the hybridization probes showed three
mismatches between its sequence and the sequence of hybridization probe STEC-II-HP-2 (Fig. 3B and C); two of these
account for the reduced melting point temperature observed

for this strain compared with prototype stx2- and stx2c-positive
strains.
We observed a large number of different melting temperatures ranging from 55 to 67°C for E. coli isolates testing positive for eae and E-hly in the LC-PCR assay (data not shown).
No subtype information for these genes was available on the
strains included in this study for examination of correlations
between the type of gene and melting point temperatures of
the hybridization probes.
Analytical sensitivity of duplex LC-PCR assays. To determine the lower limit of detection for the duplex LC-PCR
assays, we performed these assays on DNA preparations from
serial dilutions of ATCC 43895, a control strain that is positive
for stx1, stx2, eae, and E-hly. In five separate experiments, we
detected 5 ⫻ 102 CFU per reaction in three and 5 ⫻ 103 CFU
per reaction in two of the experiments performed for stx1 and
5 ⫻ 102 CFU per reaction for stx2 in all five experiments
performed (data not shown). For the simultaneous amplification and detection of eae and E-hly, we obtained a detection
limit of approximately 5 ⫻ 102 CFU per reaction for both
genes in the same number of experiments (data not shown).
We observed no difference in the lower limits of detection for
the four target genes when tested in the duplex PCR format or
individually, demonstrating that the duplex assays were not
significantly hampered by the formation of primer dimers, secondary structures, or other cross-reactions between oligonucleotides present in the reaction mixture (data not shown).
Sensitivity of duplex LC-PCR assays for detecting target
genes in fecal specimens. To assess the sensitivity of the LCPCR assays for detecting STEC in fecal specimens, we compared the abilities of these assays with those of block cycler

FIG. 2. (A) Melting curve analysis performed on amplification products of three different stx1-positive isolates. Strain B2-1 represents a typical
stx1-positive isolate (E. coli O111:H8), strains 3143-97 (E. coli O22:H8) and 3394-00 (E. coli O125:H7) are STEC isolates harboring variant stx1
sequences. (B and C) Sequence alignments with amplicons of the three different stx1 genotypes, GenBank AB015056, Z36901, anchor hybridization
probe STEC-I HP-1 (B), and sensor hybridization probe STEC-I HP-2 (C). Sequence identity is indicated by dashes. The observed melting
temperatures are indicated in the figure and next to the corresponding sequences in the alignments.
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PCR assays to detect stx1, stx2, eae, and E-hly genes in mixed
bacterial cultures harvested from primary isolation plates inoculated with spiked stool specimens. We observed the same
lower limit of direct detection for both the LC-PCR and block
cycler PCR assays for all four target genes: 5 ⫻ 103 CFU/ml of
a 50% (wt/vol) stool suspension. For these four genes, findings
from LC-PCR and block cycler PCR assays performed on
overnight bacterial growth from primary isolation plates inoculated with 2.5 CFU were both negative, while plates inoculated with stool suspension containing 25 or more CFU were
strongly positive with both assays (data not shown).
DISCUSSION
Our set of duplex assays covers the major variants of stx1 and
stx2 currently associated with human and animal disease, as
well as the genes encoding intimin (eae) and enterohemolysin
(E-hly) (Tables 4 and 5). To detect and discriminate between
the stx1 and stx2 genes, we designed a pair of degenerate primers for the amplification of both genes and used specific sets of
hybridization probes to discriminate between and within the
different families of toxin genes. We constructed the stx primers to hybridize to conserved regions within the published
sequences of the A subunit genes of Shiga toxin from S. dysenteriae type 1 (stx), prototype stx1, a sequence variant of stx1,
prototype stx2, stx2c, stx2d, and stx2e.
Because of insufficient homology between the nucleotide
sequences of the A subunit genes of stx2f and the other stx
genes (63.4% nucleotide sequence homology between stx2f and
prototype stx2), we were not able to design specific primers to
amplify this toxin variant with the other stx genes. The diagnostic importance of a false-negative reaction for this toxin
with our assay is not clear. With the exception of one isolate
from a human infant with diarrhea (strain H.I.8), the stx2f
genes to date have been detected only in E. coli strains from
apparently healthy feral pigeons (13, 22, 40). It is worth noting
that stx2f genes, while not found in combination with other stx
genes (11), were commonly present with the eae gene (22).
Based on these findings, a strategy of subsequently testing
isolates that are positive for only the eae gene in the LC-PCR
assays with the stx2f-specific PCR assay described by Schmidt et
al. (40) could be used to identify most stx2f-positive isolates
until a specific LC-PCR assay for these strains is developed.
Studies to assess the pathogenic potential of these and other stx
variant strains for humans and animals are needed to help
guide the development of diagnostic assays for clinically important STEC strains.
Excluding the stx2f-positive strains, our findings with 494
human E. coli isolates of more than 100 different serotypes and
118 other bacterial species show that the stx LC-PCR assay was
100% sensitive and specific for detecting and appropriately
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characterizing the toxin genes among the tested isolates. All
421 STEC strains positive for stx1, stx2, stx2c, stx2d, and stx2e, as
well as a strain of S. dysenteriae type 1, were positive for the
appropriate stx gene(s), and the respective stx gene variants
were clearly identified by their characteristic hybridization
probe melting points. Although we did not include a strain that
was positive for the newly described sequence variant of stx2
(Stx2-NV206) reported by Bertin et al. (3), a comparison of the
nucleotide sequence of this toxin with those of the primers and
probes used in the LC-PCR assay showed that there would be
sufficient homology between these sequences to allow detection of this stx2 variant gene by the LC-PCR assay with a
predicted Tm of 65°C.
Regarding the design of the hybridization probes, it is worth
mentioning that the 1-nucleotide mismatch between the sequence of hybridization probe STEC-II HP-2 and the sequence
of prototype stx2 (GenBank AE005296) was intentional. In
the course of evaluation experiments, hybridization probe
STEC-II HP-2, which was designed complementary to a stx2
variant (GenBank Z37725) (29), revealed greater Tm differences between all the analyzed stx2 variants than a candidate
hybridization probe with a perfect match to GenBank
AE005296.
By melting curve analysis, we detected three Tms among the
271 stx1-positive isolates for the region of the stx1 gene targeted
by the hybridization probes (Tms of 62, 65 and 68°C) (Fig. 2).
With two exceptions, the stx1-positive isolates had a Tm of
68°C. One isolate had a Tm of 62°C (3394-00, serotype O121:
H7), and another isolate (3143-97, serotype O22:H8) had a Tm
of 65°C. The nucleotide sequence of the stx1 gene from 3143-97
was identical in the region of the hybridization probes to that
reported by Paton et al. (30) for an OX3:H8 strain (GenBank
Z36901). Although heterogeneity in the nucleotide and amino
acid sequences of stx1 genes has been observed (30), no subtypes of stx1 meeting the criteria for designation specified by
O’Brien et al. (24) are currently recognized. As would be
expected, the S. dysenteriae type 1 isolate, which is positive for
the Shiga toxin gene, was positive in the LC-PCR and block
cycler PCR assays.
By melting curve analysis, we detected five Tm values (51, 55,
63, 66, and 71°C) among 278 stx2-positive isolates for the region of the stx2 gene targeted by the hybridization probes (Fig.
3). The majority of these (174) had a melting point of 71°C for
their stx2 genes. Among a subset of 117 stx2-positive strains for
which toxin subtype information was available by conventional
PCR or PCR-RFLP tests, there was good correlation between
the Tm values measured and the toxin subtype genes they
possessed: strains positive for stx2 and/or stx2c had a Tm of
71°C; strains positive for stx2d, with one exception, had a Tm of
55°C; and strains positive for stx2e, with one exception, had a
Tm of 66°C (Table 5).

FIG. 3. (A) Melting curve analyses performed on amplification products of five different stx2-positive isolates representative of the different stx2
genotypes. Strain 916-1 is a typical stx2-positive isolate (E. coli O157:H7), strain 3357-98 is a stx2e-positive isolate (E. coli O60:NM), strain 3615-99
is a STEC isolate harboring a variant stx2 sequence (E. coli Ound:NM), strain 811-1 is a stx2d-positive isolate (E. coli O128:H2), and strain 3143-97
(E. coli O22:H8) is a STEC isolate harboring a variant stx2 sequence. (B and C) Sequence alignments with amplicons of the five different stx2
genotypes, GenBank L11078 (stx2d), X81416 (stx2e), AE005296 (stx2), anchor hybridization probe STEC-II HP-1 (B) and sensor hybridization
probe STEC-II HP-2 (C). Sequence identity is indicated by dashes. The observed melting temperatures are indicated in the figure and next to the
corresponding sequences in the alignments.
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For the two exceptional strains, 3143-97 (serotype O22:H8)
and 3615-99 (serotype Ound:NM), Tms of 51 and 63°C, respectively, were obtained. Findings from the comparative nucleotide sequence analyses of the complete stx2 genes from these
two isolates suggest that these isolates possess sequence variants of stx2d and stx2e, respectively. Degrees of similarity between the sequences of 3143-97 and stx2d (29 mismatches per
1,470 bp with respect to stx2d of GenBank L11078), and between the sequences of 3615-99 and stx2e (3 mismatches per
1,236 bp with respect to stx2e of GenBank X81416) were observed. Interestingly, the G-to-A mutation in 3143-97 at position 652 of GenBank AJ313015 introduces an additional start
codon within the open reading frame of the stx2 gene. The
effect of this start codon on the level of protein translation is
not known.
The correlation of Tm values from the melting curve analyses
with toxin subtypes was an unanticipated finding from our
study. More than 99% (545 of 549) of the stx genes we examined by melting point analysis yielded Tm values that fell within
1°C of one of the four Tm values detected for the toxin subtype
control strains. As more strains are tested, it is possible that
polymorphisms in the region of the hybridization probes will
be detected that may obscure the correlation between Tm value
and toxin subtype. Testing additional strains, particularly nucleotide sequence variants of the recognized toxin subtypes, is
needed to define the range of Tm values for each toxin subtype
and to determine if the observed correlation between Tm value
and toxin subtype remains. It is worth noting that during the
course of these experiments we noticed that Tm values were
influenced by the concentration of magnesium chloride in the
reaction mixture; increasing the magnesium chloride concentration resulted in a higher observed Tm value than expected.
We did not vary each component of the reaction mixture for its
effect on Tm; however, because subtle changes may occur in the
constituents of a reaction mixture that can influence the interaction of the hybridization probes with each other or their
targets, we strongly advise running a set of control strains with
each assay when characterizing toxin genes by melting curve
analysis.
For the eae gene, we chose the PCR primers described by
Paton et al. (31) because they amplify a segment at the 5⬘ end
of eae that is conserved among STEC and enteropathogenic E.
coli (EPEC) strains, which would suggest that these primers be
used for the detection of both categories of diarrheagenic E.
coli. In contrast, primers for E-hly were complementary to an
area with minimal homology to the gene encoding E. coli
alpha-hemolysin, which shares about 70% overall DNA sequence homology with E-hly. Hybridization probes complementary to the region of the genes bounded by these sets of
primers were designed to provide good gene detection and as
much discrimination as possible between the different alleles of
each gene. LC-PCR assay findings obtained for 360 eae-positive and 356 E-hly-positive E. coli strains, as well as strains of
E. coli and 116 isolates of other bacterial species lacking these
genes, demonstrate the sensitivity and specificity of the eae and
E-hly primer and hybridization probe sequences; all the eaeand E-hly-positive organisms were positive in the LC-PCR
assays, while none of the isolates negative for these genes were
positive. As expected, the EPEC control strain was positive for
eae and negative for E-hly in the LC-PCR assay. Tms ranging
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from 55 to 67°C were observed by melting curve analyses for
eae and E-hly among the strains tested, demonstrating sequence variability in the region of the eae and E-hly genes
targeted by the hybridization probes and the potential for
additional strain discrimination.
Although the detection of eae and E-hly among STEC isolates has been done for epidemiologic purposes for nearly a
decade, the use of these genes diagnostically is still in its early
stages. Findings from several studies have shown that the majority of STEC associated with human illness also are positive
for eae and E-hly (4, 5, 34). While a positive finding of these
genes among STEC strains causing human disease appears
significant, STEC isolates lacking one or both of these genes,
for example serotypes O113:H21, O91:H21, and O104:H21,
have also been recovered from persons with clinically significant disease, and the role of these strains in causing disease
needs further study. The initial testing of samples (mixed bacterial cultures from primary isolation plates or enrichment
broths) for all four genes will allow the identification not only
of STEC associated with more significant disease but also
eae-negative and E-hly-negative STEC in subsequent studies.
Sensitivity testing experiments with serial dilutions of STEC
in culture broth or saline revealed a conservative lower limit of
detection for both the duplex LC-PCR and block cycler PCR
assays of 5 ⫻ 103 organisms per reaction for the respective
target genes. When stool samples were spiked with known
numbers of STEC, the sensitivities of the LC-PCR and block
cycler PCR assays for detecting the four target genes in overnight mixed bacterial cultures from primary isolation plates
also compared favorably, with both assays easily detecting 5 ⫻
103 CFU/ml of a 50% (wt/vol) stool suspension. DNA samples
prepared from primary isolation plates inoculated with 2.5
CFU of STEC in the presence of competing normal fecal
bacteria were negative, while samples prepared from plates
inoculated with 25 CFU or more of STEC were strongly positive.
The duplex LC-PCR assays described in this report offer
rapid cycling (1 h or less) with real-time, sequence-specific
detection of amplicons. The fluorescence-labeled hybridization
probes not only provide confidence in the identification of
target genes but also reduce the risk of experiencing product
contamination of the laboratory, because the amplification reaction, detection of PCR products, and their melting curve
analyses are conducted in a single capillary tube. Although our
current protocol for processing stool specimens for STEC requires an overnight enrichment step to achieve adequate sensitivity, the rapid amplification and reliable detection of stx1,
stx2, eae, and E-hly genes in samples should facilitate the diagnosis and management of patients infected with STEC.
While the diagnosis and management of individual patients
infected with STEC do not require an isolate, the isolation of
STEC from patient samples is critical for public health purposes. The association of the STEC target genes with a particular bacterium requires testing isolates, and isolates are still
needed for molecular subtyping (DNA fingerprinting), serologic characterization, and antimicrobial susceptibility testing
for surveillance purposes. For these reasons, clinical laboratories are strongly encouraged to consult with their public health
authorities for guidance on forwarding positive samples for
isolation of STEC. The speed at which bacterial colonies can
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be screened for target genes and have these characterized with
LC-PCR assays should facilitate the isolation of STEC and
provide epidemiologically useful information for the identification and investigation of STEC outbreaks. Although they are
currently more expensive to perform than block cycler PCR
assays, the speed, greater information, and reliability of the
results make the LC-PCR assays attractive alternatives to conventional block cycler PCR assays for the detection and characterization of STEC.
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